BCR and chronic myelogenous leukemia, BCR-ABL1 positive: The feature that uniquely defines CML is a clone-specific BCR-ABL fusion gene that encodes an oncoprotein with constitutively elevated tyrosine kinase (TK) activity, driving the pathogenesis of the disease [4-6].